MonitorCRO

What MonitorCRO does

MonitorCRO (legal name: Monitor Medikal Araştırma ve Danışmanlık) is a Türkiye-headquartered, full-service contract research organization founded in 1999 and operating from the Şişli district of Istanbul. The firm manages Phase I-IV clinical trials for global pharmaceutical, biotechnology, and medical device sponsors, with deep specialization in navigating Turkish Ministry of Health (TİTCK) and ethics committee regulatory pathways. Its credential base includes pioneering the first Phase I clinical study conducted in Türkiye in 2004 and building access to investigator sites across all four phases of clinical development. Therapeutic-area focus spans early-phase trials, Phase II-IV interventional studies, medical device investigations (including EU MDR post-market surveillance), pediatric and neonatal studies, orphan drugs and rare diseases, and PK/bioequivalence research.

The company's core technology asset is Helios EDC, a proprietary electronic data capture platform validated per FDA 21 CFR Part 11 and GAMP 5 standards. Helios EDC supports computerized system validation (IQ/OQ/PQ), full audit trail, drag-and-drop CRF design, ePRO, eConsent, randomization (IRT/IWRS), real-time monitoring dashboards with automated queries, and a dedicated post-market surveillance module for medical devices. All clinical data management services (CRF design, database management, medical coding under MedDRA and WHO-DD, data cleaning, and regulatory submission dataset preparation) run on this platform. The compliance posture is anchored by ISO 9001 (quality management), ISO 27001 (information security), ICH-GCP, GDPR plus Turkish KVKK, HIPAA, CDISC Gold Membership, and GAMP 5.

MonitorCRO generates revenue through professional-services contracts with enterprise pharmaceutical, biotechnology, and medical device sponsors. Pricing is quote-based and varies by study scope, phase, therapeutic area, and duration, with multi-year contract structures typical for full-service engagements. Customer acquisition relies on direct enterprise field sales, web-driven inbound via Request a Demo and Contact Us CTAs, LinkedIn and organic search, and participation in industry events. The company is privately held, with no parent company, private equity sponsor, or institutional investor identified in the source material, and reports 100+ dedicated professionals and 300+ completed clinical studies across its 25+ year operating history.

Name

MonitorCRO

Legal name

Monitor Medikal Araştırma ve Danışmanlık (MonitorCRO)

Website

https://monitorcro.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

MonitorCRO is a Türkiye-headquartered full-service contract research organization (founded 1999) that runs Phase I-IV clinical trials for global pharmaceutical, biotechnology, and medical device sponsors via its proprietary Helios EDC platform and Turkish regulatory expertise.

Ownership category

akta.pro rank

Product category

Contract Research Organization Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Electronic data capture
• Regulatory affairs services

Headquarters

HQ city

Sisli

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Full-service CRO offering comprehensive clinical trial solutions from regulatory approvals to final reporting. Revenue is generated through service fees for clinical operations, regulatory affairs, medical writing, data management, biostatistics, and quality assurance services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

MonitorCRO is a full-service contract research organization that plans, executes, and reports Phase I-IV clinical trials for pharmaceutical, biotechnology, and medical device companies. Service offerings span clinical operations and project management, regulatory affairs (TİTCK and ethics committee submissions), medical writing, data management and biostatistics, quality assurance, and pharmacovigilance, all supported by its proprietary Helios EDC electronic data capture platform validated per FDA 21 CFR Part 11 and GAMP 5 guidelines.

Product overview

MonitorCRO operates as a single unified platform-plus-services architecture centered on Helios EDC, its proprietary electronic data capture ecosystem. All clinical data management services (CRF design, database management, medical coding, data cleaning) are powered by and integrated with the Helios EDC platform. The company offers a full suite of complementary clinical trial services (clinical operations, regulatory affairs, medical writing, biostatistics, quality assurance) that work in conjunction with the technology platform to deliver end-to-end clinical trial solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Helios EDC: Proprietary electronic data capture (EDC) platform validated per FDA 21 CFR Part 11 and GAMP 5 guidelines, featuring drag-and-drop CRF design, real-time monitoring, ePRO, eConsent, randomization, and medical device post-market surveillance (MDR) capabilities.

Products and services

• Clinical Operations & Project Management End-to-end clinical trial management service with efficient oversight across all therapeutic fields, covering Phase I-IV studies for pharmaceutical, biotechnology, and medical device sponsors.
• Regulatory Affairs Expert regulatory guidance covering Turkish Ministry of Health (TİTCK) and ethics committee submissions, amendments, and ongoing compliance for clinical trials conducted in Türkiye.
• Medical Writing Development of protocols, informed consent forms (ICFs), clinical study reports (CSRs), manuscripts, and journal submissions by experienced medical writers.
• Data Management & EDC Services Comprehensive clinical data management services including CRF design, database setup and validation, medical coding (MedDRA, WHO-DD), data cleaning, query management, and regulatory submission-ready dataset preparation, powered by the Helios EDC platform.
• Biostatistics & Reporting Experienced biostatisticians delivering precise, statistically validated analyses and reports for regulatory submissions across clinical trial phases.
• Quality Assurance & Pharmacovigilance Comprehensive quality assurance structure with safety reporting that ensures ICH-GCP compliance, data integrity, and pharmacovigilance oversight throughout the trial lifecycle.
• Helios EDC Platform Proprietary electronic data capture ecosystem validated per FDA 21 CFR Part 11 and GAMP 5, with computerized system validation (IQ/OQ/PQ), drag-and-drop CRF design, ePRO, eConsent, randomization (IRT/IWRS), real-time monitoring, source data verification, and a dedicated MDR post-market surveillance module for medical devices.

Quantifiable outcome

• 300+ clinical studies completed
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Global Pharmaceutical CompaniescoreOthersTrusted partnership network of 20+ global pharmaceutical companies for clinical trial services. MonitorCRO provides comprehensive CRO services including clinical operations, regulatory affairs, data management, and pharmacovigilance to support pharmaceutical drug development.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Syneos Health: Recently taken private by Elliott, Syneos is a full-service biopharmaceutical solutions organization offering clinical development and commercialization services across all phases. Directly comparable to MonitorCRO across the end-to-end clinical services portfolio.
• Parexel: Major global full-service CRO taken private by EQT/Goldman in 2021, with deep Phase I-IV capabilities and dedicated biopharmaceutical and medical device practices. Directly comparable to MonitorCRO across the same service portfolio and customer segments.
• Celerion: Specialty CRO and clinical pharmacology organization with a strong focus on early-phase (Phase I) and bioequivalence studies, including first-in-human expertise. Highly comparable to MonitorCRO's Turkish Phase I pioneer positioning and PK/bioequivalence offerings.
• Medpace: Mid-to-large publicly-traded tech-enabled CRO operating globally across all phases with proprietary data management tooling. Closely comparable to MonitorCRO in the mid-size full-service CRO segment with a proprietary technology-enabled operating model.
• IQVIA: The world's largest full-service CRO, offering Phase I-IV clinical operations, biostatistics, data management, and regulatory consulting across 60+ countries. Directly comparable as a global full-service CRO competitor to MonitorCRO in pharma/biotech/medical device services, but at dramatically greater scale.
• Worldwide Clinical Trials: Mid-size global CRO focused on Phase I-IV clinical development, with therapeutic-area expertise and central lab services. Closely comparable to MonitorCRO in scale (mid-size full-service CRO) and in targeted Phase II-IV positioning.
• ICON plc: Global full-service CRO formed via the PRA Health merger, providing clinical research, data management, and consulting across all phases. Competes head-to-head with MonitorCRO for multi-region Phase II-IV programs and central laboratory services.
• Charles River Laboratories: Large public CRO offering clinical trial support alongside its early-stage research services business. Overlaps with MonitorCRO in Phase I/biopharma services, bioanalytical, and medical device research support.
• Labcorp / Covance: Large diagnostics and CRO services platform (Covance clinical services) offering Phase I-IV, central laboratory, and biopharma development services. Directly comparable in full-service clinical operations, lab testing, and data services.

Regional players

• Cromos Pharma: Regional CRO headquartered in Europe with deep operational presence in Eastern Europe, Central Asia, and Türkiye. Comparable to MonitorCRO as a regionally anchored CRO serving Türkiye and surrounding markets with full-service clinical operations and local regulatory expertise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MonitorCRO